Key facts
- This page summarizes Todd E. Simpson's Form 4 filing for Seagen Inc..
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Apr 2023, 19:50.
Todd E. Simpson - 10 Apr 2023 Form 4 Insider Report for Seagen Inc.
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 10 Apr 2023
- Net transaction value
- -$8,755,841
- SEC form
- 4
- Accepted by SEC
- 12 Apr 2023, 19:50:45 UTC
- Prior SEC filing
- 12 Apr 2023
- Next SEC filing
- 09 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Jennifer Prosba For: Todd E. Simpson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Todd E. Simpson filed Form 4 for Seagen Inc. on 12 Apr 2023.
Change
- Previous filing in this sequence was filed on 12 Apr 2023.
- Current net transaction value: -$8,755,841.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SGEN
transaction
Common Stock
Options Exercise
- Transaction value
- $694,623
- Shares
- +14,980
- Change %
- +13%
- Price
- $46.37
- Shares after
- 133,926
- Date
- 10 Apr 2023
- Ownership
- Direct
- Footnotes
- F1
SGEN
transaction
Common Stock
Sale
- Transaction value
- $3,058,017
- Shares
- -14,980
- Change %
- -11%
- Price
- $204.14
- Shares after
- 118,946
- Date
- 10 Apr 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
SGEN
transaction
Common Stock
Options Exercise
- Transaction value
- $1,871,679
- Shares
- +40,364
- Change %
- +34%
- Price
- $46.37
- Shares after
- 159,310
- Date
- 10 Apr 2023
- Ownership
- Direct
- Footnotes
- F1
SGEN
transaction
Common Stock
Sale
- Transaction value
- $8,264,125
- Shares
- -40,364
- Change %
- -25%
- Price
- $204.74
- Shares after
- 118,946
- Date
- 10 Apr 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SGEN
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -14,980
- Change %
- -27%
- Price
- $0.000000
- Shares after
- 40,364
- Date
- 10 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,980
- Exercise price
- $46.37
- Footnotes
- F5
SGEN
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -40,364
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,364
- Exercise price
- $46.37
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Footnote F2
The sales reported in this Form 4 were effected pursuant to a written plan adopted on December 9, 2022 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Footnote F3
Reflects sales of common stock executed in multiple transactions at prices ranging from $203.49 to $204.48. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F4
Reflects sales of common stock executed in multiple transactions at prices ranging from $204.49 to $205.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F5
Options vested 25% on 8/17/18 and monthly thereafter until all the options were fully vested on 8/17/21.